One‑week radiotherapy course shown to be safe and effective in the long term for early‑stage breast cancerOne‑week radiotherapy course shown to be safe and effective in the long term for early‑stage breast cancer
Research led by a Keele University oncologist has found that a one-week course of post-surgery radiotherapy is just as safe and effective as the traditional three-week course for people with early-stage breast cancer. The FAST-Forward trial, led by Keele’s Professor Murray Brunt and sponsored by The Institute of Cancer Research, London, followed more than 4,000 patients for a decade after their treatment.
GLP-1 drugs may reduce the risk of cancer progressing, study suggestsGLP-1 drugs may reduce the risk of cancer progressing, study suggests
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the Read More
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor TypesGLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
(MedPage Today) — CHICAGO — Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated with lower rates of progression to metastatic disease over a 5-year period, a propensity score-matched analysis… (MedPage Today) — CHICAGO — Use of GLP-1 receptor agonists in patients with four solid tumor types was Read More
Vanessa Trump, ex-wife of Donald Trump Jr, diagnosed with breast cancerVanessa Trump, ex-wife of Donald Trump Jr, diagnosed with breast cancer
Vanessa Trump said she underwent a medical procedure and asked the public for privacy while she focuses on her health.
Breast cancer drug is effective for treatment-resistant uterine cancerBreast cancer drug is effective for treatment-resistant uterine cancer
Uterine cancer is the deadliest cancer of the female reproductive system. Currently, clinicians treat the disease by using a mix of surgery and chemotherapy. But not everyone responds to this line of treatment, and those who fail first-line therapies are often left without next steps. Research by the Yale School of Medicine (YSM) shows that a breast cancer drug could provide new options for people suffering from treatment-resistant uterine cancer.
Study targets alcohol marketing that downplays breast cancer riskStudy targets alcohol marketing that downplays breast cancer risk
Memorial Day weekend, the unofficial start of summer, is a peak holiday for alcohol consumption, with nearly half of celebrants reporting they plan to buy alcoholic beverages. Public health experts are raising concern that only about 28% of people are aware that regular alcohol consumption increases risk for at least seven forms of cancer.
Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, ‘Scream Cream’Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, ‘Scream Cream’
(MedPage Today) — WASHINGTON — Interest in GLP-1 receptor agonists as a potential aid to sexual desire and arousal disorders took off in the field of sexual medicine — and landed with a thud. “GLP-1s are not what I would call treatments… (MedPage Today) — WASHINGTON — Interest in GLP-1 receptor agonists as a Read More
As GLP-1 drugs surge in popularity, bariatric surgery rates plunge across the USAs GLP-1 drugs surge in popularity, bariatric surgery rates plunge across the US
For a very long time, bariatric surgery, in which doctors removed a portion of the stomach, was the standard procedure for helping patients lose weight and manage obesity, alongside metabolic disorders such as diabetes, high blood pressure, and high cholesterol. However, ever since GLP-1 medications like Ozempic became available on the market, there has been Read More
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke riskPopular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes. A huge international review found that GLP-1 weight-loss drugs significantly reduce Read More
‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
As GLP-1 weight-loss medications gain traction, the peptide market is experiencing a surge in interest. A variety of peptides — commonly marketed for weight loss, muscle building, injury recovery and other uses — have emerged as largely unregulated drugs sold through both licensed compounding pharmacies and unverified vendors. The U.S. Food and Drug Administration is Read More